Blood volume expander must carry a boxed warning about increased risk of kidney injury and death

0

Intravenous news: Medpage Today report “Hydroxyethyl starch solutions used to treat hypovolemia must carry a boxed warning about increased risk of kidney injury and death, the FDA said Monday. The move comes 2 weeks after an expert advisory committee in the European Union recommended that these products be pulled from the market entirely. Hydroxyethyl starch is a key component of infusion solutions used to expand blood volume in certain clinical situations, such as septic shock or open heart surgery with cardiopulmonary bypass.”

Main page

Share.

Leave A Reply

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.